# clm_86D501AB2F5C

subject: Vertex Pharmaceuticals (/record/vertex-pharmaceuticals.md)  
predicate: quarterly_research_and_development  
value: 493,751,000 United States dollar  
valid_from: 2021-09-30  
valid_to: 2022-03-31  
published: 2021-11-03  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_CF81367A05A7  
last_updated: 2026-11-08  
cite: AsOf. "Vertex Pharmaceuticals quarterly research and development: 493,751,000 United States dollar", as of 2021-09-30 (until 2022-03-31). Claim clm_86D501AB2F5C, https://asof.is/claim/clm_86D501AB2F5C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/875320/000087532021000033/0000875320-21-000033-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2021, filed 2021-11-03  

## Sources

- https://www.sec.gov/Archives/edgar/data/875320/000087532021000033/0000875320-21-000033-index.htm (primary, SEC EDGAR 10-Q Q3 FY2021, published 2021-11-03)

## Supersedes

- [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | quarterly_research_and_development | 1,407,090,000 United States dollar | valid 2021-06-30 to 2021-09-30 | conf 0.95 | superseded | superseded_by [clm_86D501AB2F5C](/claim/clm_86D501AB2F5C.md) | [clm_DC884CD97A0D](/claim/clm_DC884CD97A0D.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.